Clinical Trial Update: Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR [Phase 4]

View source ↗

Summary

Phase 4 trial assessing lanreotide Autogel in acromegaly patients previously treated with octreotide LAR has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Acromegaly | Phase 4 | Status: COMPLETED